These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17516739)

  • 21. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy.
    Baraban E; Ding CC; White M; Vohra P; Simko J; Boyle K; Guo C; Zhang M; Dobs A; Ketheeswaran S; Liang F; Epstein JI
    Am J Surg Pathol; 2022 Dec; 46(12):1650-1658. PubMed ID: 36006769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy.
    Bostwick DG; Ramnani D; Cheng L
    Urol Clin North Am; 1999 Aug; 26(3):465-79. PubMed ID: 10494285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy.
    Langer JE; Rovner ES; Coleman BG; Yin D; Arger PH; Malkowicz SB; Nisenbaum HL; Rowling SE; Tomaszewski JE; Wein AJ; Jacobs JE
    J Urol; 1996 Jan; 155(1):228-31. PubMed ID: 7490841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.
    Egan AJ; Lopez-Beltran A; Bostwick DG
    Am J Surg Pathol; 1997 Aug; 21(8):931-5. PubMed ID: 9255256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance.
    Montironi R; Mazzucchelli R; Algaba F; Lopez-Beltran A
    J Clin Pathol; 2000 Sep; 53(9):655-65. PubMed ID: 11041054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphatic Vascularization in Prostate Adenocarcinoma: Correlation with Tumor Grade, Androgen Withdrawal and Prognosis.
    Ambrosio MR; Rocca BJ; Barone A; Ginori A; Crivelli F; Pirtoli L; Del Vecchio MT
    Anticancer Res; 2015 Oct; 35(10):5595-600. PubMed ID: 26408731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological changes induced by therapies in the benign prostate and prostate adenocarcinoma.
    Petraki CD; Sfikas CP
    Histol Histopathol; 2007 Jan; 22(1):107-18. PubMed ID: 17128417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
    Smart R
    N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
    Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
    Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benign mimickers of the prostate cancer. Diagnostic challenges].
    Compérat E; Varinot J; Srigley JR
    Ann Pathol; 2013 Aug; 33(4):237-46. PubMed ID: 23954116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foamy gland high-grade prostatic intraepithelial neoplasia.
    Berman DM; Yang J; Epstein JI
    Am J Surg Pathol; 2000 Jan; 24(1):140-4. PubMed ID: 10632499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes and Prognostic Factors in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Recurrence after Radical Prostatectomy.
    Ravi P; Karnes RJ; Rangel LJ; Pagliaro LC
    J Urol; 2018 Nov; 200(5):1075-1081. PubMed ID: 29709664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
    Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
    Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostatic intraepithelial pagetoid histiocyte: a potential diagnostic pitfall.
    Kanomata N; Kozuka Y; Moriya T
    Pathol Int; 2011 Sep; 61(9):551. PubMed ID: 21884306
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
    J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic adenocarcinoma with glomeruloid features.
    Pacelli A; Lopez-Beltran A; Egan AJ; Bostwick DG
    Hum Pathol; 1998 May; 29(5):543-6. PubMed ID: 9596281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostatic intraepithelial neoplasia].
    Molinié V
    Ann Pathol; 2001 Jun; 21(3):245-54. PubMed ID: 11468562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.
    Fu AZ; Tsai HT; Haque R; Yood MU; Cassidy-Bushrow AE; Van Den Eeden SK; Keating NL; Smith MR; Zhou Y; Aaronson DS; Potosky AL
    J Urol; 2017 Jun; 197(6):1448-1454. PubMed ID: 28007467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.